Assessing Nurix Therapeutics (NRIX) Valuation After Recent Share Price Volatility [Yahoo! Finance]
Nurix Therapeutics, Inc. - Common stock (NRIX)
Company Research
Source: Yahoo! Finance
Nurix Therapeutics (NRIX) has drawn attention after a recent 1 day decline of 4.3%, adding to a 3.4% drop over the past week, while the stock has shown a 54.9% gain in the past 3 months. See our latest analysis for Nurix Therapeutics. The recent pullback sits against a mixed picture, with the share price at US$18.56 and short term weakness contrasting with a strong 90 day share price return. However, the 1 year total shareholder return remains negative, hinting that sentiment has improved recently but longer term holders have not yet fully recovered. If you are watching moves in biotech and want a broader view of opportunities, it could be a good moment to scan healthcare stocks for other ideas. With Nurix still loss making, growing revenue at 33.8% annually and trading around a 41% discount to the average analyst price target of US$29.59, you have to ask: is this a genuine opportunity, or is the market already pricing in future growth? On a P/S basis, Nurix Therapeutics tr
Show less
Read more
Impact Snapshot
Event Time:
NRIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NRIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NRIX alerts
High impacting Nurix Therapeutics, Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
NRIX
News
- Nurix Therapeutics (NRIX) Is Down 7.4% After Wider 2025 Losses And New ESOP Share Shelf - What's Changed [Yahoo! Finance]Yahoo! Finance
- Nurix Therapeutics, Inc. (NRIX): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Stifel Raised Nurix Therapeutics, Inc. (NRIX) Price Target to $35 and Maintains Buy Ahead of 2026 Catalysts [Yahoo! Finance]Yahoo! Finance
- Nurix Therapeutics (NASDAQ:NRIX) had its price target raised by analysts at Royal Bank Of Canada from $28.00 to $30.00. They now have an "outperform" rating on the stock.MarketBeat
- Nurix Therapeutics (NASDAQ:NRIX) was given a new $35.00 price target on by analysts at Stifel Nicolaus.MarketBeat
NRIX
Earnings
- 1/28/26 - Beat
NRIX
Sec Filings
- 2/3/26 - Form 4
- 1/30/26 - Form 4
- 1/30/26 - Form 4
- NRIX's page on the SEC website